Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington’s disease

By Schapira A.  

Human Molecular Genetics, Vol. 10, Iss. 17, 2001-08 ,pp. : 1829-1845

Oxford University Press

Access to resources Recommend Favorite

Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease

By Chan Edmond Y.W.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1939-1951

Oxford University Press

Access to resources Recommend Favorite

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects

By Borchelt D.R.  

Human Molecular Genetics, Vol. 11, Iss. 17, 2002-06 ,pp. : 1927-1937

Oxford University Press

Access to resources Recommend Favorite

Compensatory changes in the ubiquitinproteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients

By Seo Hyemyung   Kim Woori   Isacson Ole  

Human Molecular Genetics, Vol. 17, Iss. 20, 2008-10 ,pp. : 3144-3153

Oxford University Press

Access to resources Recommend Favorite

Regional and cellular gene expression changes in human Huntington's disease brain

By Hodges Angela   Strand Andrew D.   Aragaki Aaron K.   Kuhn Alexandre   Sengstag Thierry   Hughes Gareth   Elliston Lyn A.   Hartog Cathy   Goldstein Darlene R.   Thu Doris   Hollingsworth Zane R.   Collin Francois   Synek Beth   Holmans Peter A.   Young Anne B.   Wexler Nancy S.   Delorenzi Mauro   Kooperberg Charles   Augood Sarah J.   Faull Richard L.M.   Olson James M.  

Human Molecular Genetics, Vol. 15, Iss. 6, 2006-03 ,pp. : 965-977

Oxford University Press

Access to resources Recommend Favorite